SoftView Technology from Riverain Medical Extends Digital Radiography Systems from Siemens

Siemens HealthcareSiemens has enhanced its digital radiography systems with technology that produces a soft tissue image of the chest. Riverain Medical's SoftView Enhanced Chest Imaging technology automatically suppresses the ribs and clavicles to improve the visibility of soft tissue structures in the lungs, allowing the physician to interpret pulmonary nodules with greater certainty. Furthermore, as SoftView uses the existing chest X-ray to produce the soft tissue image, it eliminates additional dose and motion artifacts commonly associated with dual energy solutions.

Ribs and clavicles on a chest X-ray often make it difficult for the physician to obtain a clear evaluation of the lung tissue. Until now, radiologists have used dual energy technology to improve the visibility of the lungs. The technique involves the successive acquisition of two images consisting of a low and a high energy spectrum. The physician can then use these two images to visualize the soft tissue in the lung.

Siemens is now offering SoftView from Riverain Medical with Ysio, their latest digital radiography system. SoftView enables the physician to acquire a soft tissue image faster and without any additional radiation dose for the patient. “Patient positioning, radiation dose and inspiration can make the interpretation of a chest X-ray challenging. SoftView suppresses the ribs and clavicles on a chest X-ray to improve the clarity of the image, even when image quality is low," explains Dr. Stefan Palmers, Ghent Hospital, Belgium, who is already working with the technology. "Siemens Healthcare's Ysio and Riverain Medical's SoftView technologies together produce optimal image quality."

SoftView is available from Siemens as a one-stop solution with Ysio, but can also be acquired as an upgrade for other digital radiography systems from Siemens. The software can easily be integrated and requires no adaptation of the clinical protocols for chest X-rays.

The products mentioned here are not commercially available in all countries. Due to regulatory reasons the future availability in any country cannot be guaranteed. Further details are available from the local Siemens organizations.

The outcomes achieved by the Siemens customers described herein were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that others will achieve the same results.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit: http://www.siemens.com/healthcare

About Riverain Medical
Riverain Medical is a Dayton, Ohio based medical technology innovator that develops practical solutions to save and improve the quality of people's lives, through the early detection of disease. The company's technologies are designed to enhance the expert skills of physicians to improve patient outcomes without additional radiation dose or procedures. For more information please visit: www.riverainmedical.com.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

Bayer Grants4Apps® Dealmaker Berlin 2017

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts...